Thyroid Disease

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 467,XIV-482,XIV

  Weetman, Anthony P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61449182593     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50038-X     Document Type: Chapter

References (141)

1. D.D. Adams and H.D. Purves (1956) Abnormal responses in the assay of thyrotrophin. Proc. Univ. Otago Med. School 34 11-12.
2. G. Aichinger, H. Fill and G. Wick (1985) In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto's thyroiditis. Lab. Invest. 52 132-140.
3. R.A. Ajjan, P.F. Watson, R.S. McIntosh and A.P. Weetman (1996) Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin. Exper. Immunol. 105 523-528.
4. R.A. Ajjan, E.H. Kemp, E.A. Waterman, P.F. Watson, T. Endo, T. Onaya and A.P. Weetman (2000) Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with automimmune thyroid disease. J. Clin. Endocrinol. Metab. 85 2020-2027.
5. T. Ando and T.F. Davies (2003) Postpartum autoimmune thyroid disease: the potential role of fetal microchimerism. J. Clin. Endocrinol. Metab. 88 2965-2971.
6. T. Ando, M. Imaizumi, P. Graves, P. Unger and T.F. Davies (2003) Induction of thyroid-stimulating hormone receptor autoimmunity in hamsters. Endocrinology 144 671-680.
7. T. Ando, R. Latif, S. Daniel, K. Eguchi and T.F. Davies (2004) Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology 145 5185-5193.
8. S. Ansar-Ahmed, P.R. Young and W.J. Penhale (1983) The effects of female sex steroids on the development of autoimmune thyroiditis in thymectomized and irradiated rats. Clin. Exper. Immunol. 54 351-358.
9. K. Arikawa, Y. Ichikawa, T. Yoshida, T. Shinozawa, M. Homma, N. Momotani and K. Ito (1985) Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action. J. Clin. Endocrinol. Metab. 60 953-959.
10. M.P. Armengol, C.B. Cardoso-Schmidt, M. Fernandez, X. Ferrer, R. Pujol-Borrell and M. Juan (2003) Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J. Immunol. 170 6320-6328.
11. N. Bagchi, T.R. Brown and R.S. Sundick (1995) Thyroid cell injury is an initial event in the induction of autoimmune thyroiditis by iodine in obese strain chickens. Endocrinology 136 5054-5060.
12. L. Bartalena, F. Bogazzi, M.L. Tanda, L. Manetti, E. Dell-Unto and E. Martino (1995) Cigarette smoking and the thyroid. Eur. J. Endocrinol. 133 507-512.
13. L. Bartalena, A. Pinchera and C. Marcocci (2000) Management of Graves' ophthalmopathy: reality and perspectives. Endocr. Rev. 21 168-199.
14. S. Blanchin, V. Estienne, J.M. Durand-Gorde, P. Carayon and J. Ruf (2003) Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology 144 5422-5429.
15. U. Bogner, L. Hegedus, J.M. Hansen, R. Finke and H. Schleusener (1995) Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis. Eur. J. Endocrinol. 132 69-74.
16. G.F. Bottazzo, R. Pujol-Borrell, T. Hanafusa and M. Feldmann (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2 1115-1119.
17. J.D. Bretz and J.R. Baker (2001) Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? Clin. Endocrinol. 55 1-11.
18. T.H. Brix, K.O. Kyvik and L. Hegedus (1998) What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 8 727-734.
19. T.H. Brix, K.O. Kyvik and L. Hegedus (2000) A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85 536-539.
20. T.H. Brix, P.S. Hansen, K.O. Kyvik and L. Hegedus (2004) Aggregation of thyroid autoantibodies in first-degree relatives of patients with autoimmune thyroid disease is mainly due to genes: a twin study. Clin. Endocrinol. 60 329-334.
21. W.G. Butscher, P.W. Ladenson and C.L. Burek (2001) Whole-blood proliferation assay for autoimmune thyroid disease: comparison to density-gradient separated-peripheral blood lymphocytes. Thyroid 11 531-537.
22. C. Carella, G. Mazziotti, F. Morisco, G. Manganella, M. Rotondi, C. Tuccillo, F. Sorvillo, N. Caporaso and G. Amato (2001) Longterm outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J. Clin. Endocrinol. Metab. 86 1925-1929.
23. C.R. Chen, P. Pichurin, Y. Nagayama, F. Latrofa, B. Rapoport and S.M. McLachlan (2003) The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J. Clin. Invest. 111 1897-1904.
24. L. Chiovato, P. Bassi, F. Santini, C. Mammoli, P. Lapi, P. Carayon and A. Pinchera (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 77 1700-1705.
25. L. Chiovato, F. Latrofa, L.E. Braverman, F. Pacini, M. Capezzone, L. Masserini, L. Grasso and A. Pinchera (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann. Intern. Med. 139 346-351.
26. B.Y. Cho, W.B. Kim, J.H. Chung, K.H. Yi, Y.K. Shong, H.K. Lee and C.S. Koh (1995) High prevalence and little change in TSH receptor blocking antibody tires with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis. Clin. Endocrinol. 43 465-471.
27. S.B. Cohen, C.D. Dijkstra and A.P. Weetman (1988) Sequential analysis of experimental autoimmune thyroiditis induced by neonatal thymectomy in the Buffalo strain rat. Cell. Immunol. 114 126-136.
28. A.J. Coles, M. Wing, S. Smith, F. Coraddu, S. Greer, C. Taylor, A. Weetman, G. Hale, V.K. Chatterjee, H. Waldmann and A. Compston (1999) Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354 1691-1695.
29. J.E. Collins, J.E. Heward, J.M.M. Howson, H. Foxall, J. Carr-Smith, J.A. Franklyn and S.C.L. Gough (2004) Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J. Clin. Endocrinol. Metab. 89 6336-6339.
30. S. Costagliola, M.C. Many, M. Stalmans-Falys, M. Tonacchera, G. Vassart and M. Ludgate (1994) Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model. Endocrinology 135 2150-2159.
31. S. Costagliola, P. Rodien, M.C. Many, M. Ludgate and G. Vassart (1998) Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J. Immunol. 160 1458-1465.
32. S. Costagliola, N.G. Morgenthaler, R. Hoermann, K. Badenhoop, J. Struck, D. Freitag, S. Peortl, W. Weglohner, J.M. Hollidt, B. Quadbeck, J.E. Dumont, P.M. Schumm-Draeger, A. Bergmann, K. Mann, G. Vassart and K.H. Usadel (1999) Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J. Clin. Endocrinol. Metab. 84 90-97.
33. P. Creemers, N.R. Rose and Y.M. Kong (1983) Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J. Exper. Med. 157 559-571.
34. L. Crisa, J.P. Mordes and A.A. Rossini (1992) Autoimmune diabetes mellitus in the BB rat. Diabetes/Metab. Rev. 8 4-37.
35. T.F. Davies, E. Roti, L.E. Braverman and L.J. DeGroot (1998) Thyroid controversy—stimulating antibodies. J. Clin. Endocrinol. Metab. 83 3777-3785.
36. C.M. Dayan, N.R. Chu, M. Londei, B. Rapoport and M. Feldmann (1993) T-cells involved in human autoimmune disease are resistant to tolerance induction. J. Immunol. 151 1606-1613.
37. H.J. De Assis-Paiva, D.C. Rayner, I.M. Roitt and A. Cooke (1989) Cellular infiltration in induced rat thyroiditis: phenotypic analysis and relationship to genetic restriction. Clin. Exper. Immunol. 75 106-112.
38. T.W. De Bruin, N.A. Patwardhan, R.S. Brown and L.E. Braverman (1988) Graves' disease: changes in TSH receptor and anti-microsomal antibodies after thyroidectomy. Clin. Exper. Immunol. 72 481-485.
39. A. Di Cerbo, R. Di Paola, M. Bonati, M. Zingrillo, V. De Filippis and D. Corda (1995) Subgroups of Graves' patients identified on the basis of the biochemical activities of their immunoglobulins. J. Clin. Endocrinol. Metab. 80 2785-2790.
40. H.A. Drexhage (1996) Autoimmunity and thyroid growth. Where do we stand? Eur. J. Endocrinol. 135 39-45.
41. C. Duthoit, V. Estienne, F. Delom, J.M. Durand-Gorde, B. Mallet, P. Carayon and J. Ruf (2000) Production of immunoreactive thyroglobulin C-terminal fragments during thyroid hormone synthesis. Endocrinology 141 2518-2525.
42. M. ElRehewy, Y.M. Kong, A.A. Giraldo and N.R. Rose (1981) Syngeneic thyroglobulin is immunogenic in good responder mice. Eur. J. Immunol. 11 146-151.
43. M. Elsheikh, J.A. Wass and G.S. Conway (2001) Autoimmune thyroid syndrome in women with Turner's syndrome—the association with karyotype. Clin. Endocrinol. 55 223-226.
44. J. Gilquin, J.P. Viard, V. Jubault, C. Sert and M.D. Kazatchkine (1998) Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet 352 1907-1908.
45. C. Giordano, G. Stassi, R. De-Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi and A. Galluzzo (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275 960-963.
46. M. Gora, A. Gardas, W. Wiktorowicz, P. Hobby, P.F. Watson, A.P. Weetman, B.J. Sutton and J.P. Banga (2004) Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis. Clin. Exper. Immunol. 136 137-144.
47. B. Grubeck-Loebenstein, M. Turner, K. Pirich, H. Kassal, M. Londei, W. Waldhausl and M. Feldmann (1990) CD4+ T-cell clones from autoimmune thyroid tissue cannot be classified according to their lymphokine production. Scand. J. Immunol. 32 433-440.
48. F. Hamilton, M. Black, M.A. Farquharson, C. Stewart and A.K. Foulis (1991) Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin. Exper. Immunol. 83 64-68.
49. Y. Hidaka, N. Amino, Y. Iwatani, E. Itoh, M. Matsunaga and H. Tamaki (1993) Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Grave's disease. J. Clin. Endocrinol. Metab. 77 1667-1670.
50. M. Iitaka, N. Momotani, T. Hisaoka, J.Y. Noh, N. Ishikawa, J. Ishii, S. Katayama and K. Ito (1998) TSH receptor antoibody-associayed thyroid dysfunction following subacute thyroiditis. Clin. Endocrinol. 48 445-453.
51. Y. Iwatani, N. Amino, Y. Hidaka, T. Kaneda, K. Ichihara, H. Tamaki, F. Matsuzuka, S. Fukata, K. Kuma and K. Miyai (1992) Decreases in alpha beta T-cell receptor negative T-cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis. Clin. Exper. Immunol. 87 444-449.
52. R. Jansson, A. Karlsson and U. Forsum (1984) Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin. Exper. Immunol. 58 264-272.
53. R. Jansson, P.A. Dahlberg, B. Winsa, O. Meirik, J. Safwenberg and A. Karlsson (1987) The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women. Acta Endocrinol. 116 321-325.
54. J.C. Jaume, J. Guo, D.L. Pauls, M. Zakarija, J.M. McKenzie, J.A. Egeland, C.L. Burek, N.R. Rose, W.H. Hoffman, B. Rapoport and S.M. McLachlan (1999) Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic “fingerprints”. J. Clin. Endocrinol. Matab. 84 1424-1431.
55. T.Y. Kim, Y.J. Park, J.K. Hwang, J.Y. Song, K.S. Park, B.Y. Cho and D.O.J. Park (2003) A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13 919-925.
56. A. Kojima, Y. Tanaka-Kojima, T. Sakakura and Y. Nishizuka (1976) Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab. Invest. 34 550-557.
57. I. Komiya, T. Yamada, A. Sato, T. Kouki, T. Nishimori and N. Takasu (2001) Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. J. Clin. Endocrinol. Metab. 86 3540-3544.
58. Y.C. Kong, L.C. Lomo, R.W. Motte, A.A. Giraldo, J. Baisch, G. Strauss, G.J. Hammerling and C.S. David (1996) HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exper. Med. 184 1167-1172.
59. Y.M. Kong, A.A. Giraldo, H. Waldmann, S.P. Cobbold and B.E. Fuller (1989) Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyrogolobulin-activated and TSH-induced suppression. Clin. Immunol. Immunopathol. 51 38-54.
60. K. Kotsa, P.F. Watson and A.P. Weetman (1997) A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin. Endocrinol. 46 551-554.
61. Z. Kraiem, N. Lahat, B. Glaser, E. Baron, O. Sadeh and M. Sheinfeld (1987) Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis. Clin. Endocrinol. 27 409-421.
62. A. Kretowski, N. Wawrusiewicz, K. Mironczuk, J. Mysliwiec, M. Kretowska and I. Kinalska (2003) Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease. J. Clin. Endocrinol. Metab. 88 4945-4949.
63. P. Laurberg, B. Nygaard, D. Glinoer, M. Grussendorf and J. Orgiazzi (1998) Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur. J. Endocrinol. 139 584-586.
64. M. Londei, G.F. Bottazzo and M. Feldmann (1985) Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 228 85-89.
65. M. Ludgate and G. Baker (2002) Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin. Exper. Immunol. 127 193-198.
66. M.E. Ludgate and G. Vassart (1995) The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases. Baillière's Clin. Endocrinol. Metab. 9 95-113.
67. W.A. MacKenzie, A.E. Schwartz, E.W. Friedman and T.F. Davies (1987) Intrathyroidal T-cell clones from patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 64 818-824.
68. T. Mandrup-Poulsen, J. Nerup, J.I. Reimers, F. Pociot, H.U. Andersen, A. Karlsen, U. Bjerre and R. Bergholdt (1996) Cytokines and the endocrine system. II. Reoles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and autoimmune endocrine diseases. Eur. J. Endocrinol. 134 21-30.
69. M.C. Many, S. Costagliola, M. Detrait, F. Denef, G. Vassart and M.C. Ludgate (1999) Development of an animal model of autoimmune thyroid eye disease. J. Immunol. 162 4966-4974.
70. M. Marazuela (1999) Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur. J. Endocrinol. 140 287-290.
71. F.M. Marelli-Berg, A. Weetman, L. Frasca, S.J. Deacock, N. Imami, G. Lombardi and R.I. Lechler (1997) Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T-cells and deletion of CD45RA+ T-cells. J. Immunol. 159 5853-5861.
72. A. Martin and T.F. Davies (1992) T-cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T-cell problems. Thyroid 2 247-261.
73. A. Matos-Santos, E.L. Nobre, J.G. Costa, P.J. Nogueira, A. Macedo, A. Galvao-Teles and J.J. de Castro (2001) Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre. Clin. Endocrinol. 55 15-19.
74. N. Matsuura, Y. Yamada, Y. Nohara, J. Konishi, K. Kasagi, K. Endo, H. Kojima and K. Wataya (1980) Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N. Engl. J. Med. 303 738-741.
75. R.S. McIntosh, P.F. Watson and A.P. Weetman (1997) Analysis of the T-cell receptor V alpha repertoire in Hashimoto's thyroiditis: evidence for the restricted accumulation of CD8+ T-cells in the absence of CD4+ T-cell restriction. J. Clin. Endocrinol. Metab. 82 1140-1146.
76. R. McIntosh, P. Watson and A. Weetman (1998) Somatic hypermutation in autoimmune thyroid disease. Immunol. Rev. 162 219-231.
77. S.M. McLachlan and B. Rapoport (1992) The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr. Rev. 13 192-206.
78. S.M. McLachlan, J. Taverne, M.C. Atherton, A. Cooke, S. Middleton, C.A. Pegg, F. Clark and B. Rees Smith (1990) Cytokines, thyroid autoantibody synthesis and thyroid cell survival in culture. Clin. Exper. Immunol. 79 175-181.
79. R.A. Metcalfe, Y.S. Oh, C. Stroud, K. Arnold and A.P. Weetman (1997) Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease. Autoimmunity 25 65-72.
80. R.N. Miguel, J. Sanders, J. Jeffreys, H. Delpraetere, M. Evans, T. Richards, T.L. Blundell, B. Rees Smith and J. Furmaniak (2004) Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modelling. Thyroid 14 991-1011.
81. A.F. Muller, H.A. Drexhage and A. Berghout (2001) Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr. Rev. 22 605-630.
82. H.P. Ng, J.P. Banga and A.W. Kung (2004) Development of a murine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase. Endocrinology 145 809-816.
83. M. Nilsson, J. Husmark, U. Bjorkman and L.E. Ericson (1998) Cytokines and thyroid epithelial integrity: interleukin-1 alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J. Clin. Endocrinol. Metab. 83 945-952.
84. B. Noble, T. Yoshida, N.R. Rose and P.E. Bigazzi (1976) Thyroid antibodies in spontaneous autoimmune thyroiditis in the Buffalo rat. J. Immunol. 117 1447-1455.
85. I. Okayasu, Y.M. Kong and N.R. Rose (1981) Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol. 20 240-245.
86. M. Okumura, Y. Hidaka, F. Matsuzuka, K. Takeoka, H. Tada, K. Kuma and N. Amino (1999) CD30 expression and interleukin-4 and interferon-gamma production of intrathyroidal lymphocytes in Graves' disease. Thyroid 9 333-339.
87. S. Othman, D.I. Phillips, A.B. Parkes, C.J. Richards, B. Harris, H. Fung, C. Darke, R. John, R. Hall and J.H. Lazarus (1990) A longtern follow-up of postpartum thyroiditis. Clin. Endocrinol. 32 559-564.
88. F. Pacini, T. Vorotsova, E. Molinaro, E. Kuchinskaya, L. Agate, E. Shavrova, L. Astachova, L. Chiovato and A. Pinchera (1998) Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet 352 763-766.
89. E.N. Pearce, A.P. Farwell and L.E. Braverman (2003) Thyroiditis. N. Engl. J. Med. 348 2646-2655.
90. W.J. Penhale and P.R. Young (1988) The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis. Clin. Exper. Immunol. 72 288-292.
91. W.J. Penhale, A. Farmer, R.P. McKenna and W.J. Irvine (1973) Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin. Exper. Immunol. 15 225-236.
92. M. Pfaltz and C.E. Hedinger (1986) Abnormal basement membrane structures in autoimmune thyroid disease. Lab. Invest. 55 531-539.
93. D.I. Phillips, C. Osmond, J. Baird, A. Huckle and B. Rees Smith (2002) Is birthweight associated with thyroid autoimmunity? A study in twins. Thyroid 12 377-380.
94. L.C. Pontes de Carvalho, G. Wick and I.M. Roitt (1981) Requirement of T-cells for the development of spontaneous autoimmune thyroiditis in obese strain chickens. J. Immunol. 126 750-753.
95. S. Quaratino, E. Badami, Y.Y. Pang, I. Bartok, J. Dyson, D. Kioussis, M. Londei and L. Miauri (2004) Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat. Med. 10 920-926.
96. W. Raber, A. Gessl, P. Nowotny and H. Vierhapper (2002) Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid 12 725-731.
97. B. Rapoport, G.D. Chazenbalk, J.C. Jaume and S.M. McLachlan (1998) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr. Rev. 19 673-716.
98. D. Reinwein, G. Benker, M.P. Konig, A. Pinchera, H. Schatz and H. Schleusener (1986) Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey. J. Endocrinol. Invest. 9(Suppl 2), 1-36.
99. D.P. Rennie, A.M. McGregor, D. Keast, A.P. Weetman, S.M. Foord, C. Dieguez, E.D. Williams and R. Hall (1983) The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology 112 326-330.
100. C.G. Roberts and P.W. Ladenson (2004) Hypothyroidism. Lancet 363 793-803.
101. I.M. Roitt, D. Doniach, P.N. Campbell and R. Vaughn Hudson (1956) Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet ii 820-821.
102. N.R. Rose and E. Witebsky (1956) Studies in organ specificity, V changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J. Immunol. 76 417-427.
103. C. Ruwhof and H.A. Drexhage (2001) Iodine and thyroid autoimmune disease in animal models. Thyroid 11 427-436.
104. A.M. Saboori, N.R. Rose, S.C. Yuhasz, L.M. Amzel and C.L. Burek (1999) Peptides of human thyroglobulin reactive with sera of patients with autoimmune thyroid disease. J. Immunol. 163 6244-6250.
105. S. Sakaguchi and N. Sakaguchi (1989) Organ-specific autoimmune disease induced in mice by elimination of T-cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J. Immunol. 142 471-480.
106. S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. Itoh, Y. Kuniyasu, T. Nomura, M. Toda and T. Takahashi (2001) Immunologic tolerance maintained by CD25+CD4+regulatory T-cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182 18-32.
107. J. Sanders, M. Evans, L.D. Premawardhana, H. Deparaetere, J. Jeffreys, T. Richards, J. Furmaniak and B. Rees-Smith (2003) Human monoclonal thyroid stimulating autoantibody. Lancet 362 126-128.
108. K.M. Schwartz, V. Fatourechi, D.D. Ahmed and G.R. Pond (2002) Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J. Clin. Endocrinol. Metab. 87 438-446.
109. L. Schwarz-Lauer, G.D. Chazenbalk, S.M. McLachlan, Y. Ochi, Y. Nagayama and B. Rapoport (2002) Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid 12 115-120.
110. G.D. Sempowski, S.J. Cross, C.S. Heinly, R.M. Scearce and B.F. Haynes (2004) CD7 and CD28 are required for murine CD4+CD25+ regulatory T-cell homeostasis and prevention of thyroiditis. J. Immunol. 172 787-794.
111. T.J. Smith (2005) Insights into the role of fibroblasts in human autoimmune diseases. Clin. Exper. Immunol. 141 388-397.
112. G. Stassi, M. Todaro, F. Bucchieri, A. Stoppacciaro, F. Farina, G. Zummo, R. Testi and R. De Maria (1999) Fas/Fas ligand-driven T-cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J. Immunol. 162 263-267.
113. N.R. Steel, D.R. Weightman, J.J. Taylor and P. Kendall-Taylor (1984) Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism. Br. Med. J. 288 1559-1562.
114. V. Stenszky, L. Kozma, C. Balazs, S. Rochlitz, J.C. Bear and N.R. Farid (1985) The genetics of Graves' disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metab. 61 735-740.
115. T.G. Strieder, M.F. Prummel, J.G. Tijssen, E. Endert and W.M. Wiersinga (2003) Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin. Endocrinol. 59 396-401.
116. S. Sugihara, H. Fujiwara, H. Niimi and G.M. Shearer (1995) Selfthyroid epithelial cell (TEC)-reactive CD8+ T-cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC. J. Immunol. 155 1619-1628.
117. N. Takasu, T. Yamada, M. Takasu, I. Komiya, Y. Nagasawa, T. Asawa, T. Shinoda, T. Aizawa and Y. Koizumi (1992) Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N. Engl. J. Med. 326 513-518.
118. N. Tandon, M. Freeman and A.P. Weetman (1991) T-cell responses to synthetic thyroid peroxidase peptides in autoimmune thyroid disease. Clin. Exper. Immunol. 86 56-60.
119. N. Tandon, M.A. Freeman and A.P. Weetman (1992) T-cell responses to synthetic TSH receptor peptides in Graves' disease. Clin. Exper. Immunol. 89 468-473.
120. N. Tandon, S.L. Yan, B.P. Morgan and A.P. Weetman (1994) Expression and function of multiple regulators of complement activation in autoimmune thyroid disease. Immunology 81 643-647.
121. Y. Tomer and T.F. Davies (1993) Infection, thyroid disease, and autoimmunity. Endocr. Rev. 14 107-120.
122. Y. Tomer and T.F. Davies (2003) Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24 694-717.
123. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, M.H. Herr, I. Dahlman, F. Payne, D. Smyth, C. Lowe, R.C. Twells, S. Howlett, B. Healy, S. Nutland, H.E. Rance, V. Everett, L.J. Smink, A.C. Lam, H.J. Cordell, N.M. Walker, C. Bordin, J. Hulme, C. Motzo, F. Cucca, J.F. Hess, M.L. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K.M. Gillespie, D.E. Undlien, K.S. Ronningen, C. Guja, C. Ionescu-TirgoviŸte, D.A. Savage, A.P. Maxwell, D.J. Carson, C.C. Patterson, J.A. Franklyn, D.G. Clayton, L.B. Peterson, L.S. Wicker, J.A. Todd and S.C. Gough (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 506-511.
124. M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark, J. Grimley-Evans, D.M. Hasan, H. Rodgers and F. Tunbridge (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. 43 55-68.
125. M.R. Velaga, V. Wilson, C.E. Jennings, C.J. Owen, S. Herington, P.T. Donaldson, S.G. Ball, R.A. James, R. Quinton, P. Perros and S.H.S. Pearce (2004) The codon 620 trytophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Grave's disease. J. Clin. Endocrinol. Metab. 89 5862-5865.
126. A.O. Vladutiu and N.R. Rose (1971) Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 174 1137-1139.
127. R. Volpe (1988) The immunoregulatory disturbance in autoimmune thyroid disease. Autoimmunity 2 55-72.
128. P.F. Watson, A.P. Pickerill, R. Davies and A.P. Weetman (1994) Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J. Clin. Endocrinol. Metab. 79 355-360.
129. A.P. Weetman (2000) Graves' disease. N. Engl. J. Med. 343 1236-1248.
130. A.P. Weetman and A.M. McGregor (1994) Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15 788-830.
131. A.P. Weetman, A.M. McGregor, M.H. Wheeler and R. Hall (1984) Extrahyroidal sites of autoantibody synthesis in Graves' disease. Clin. Exper. Immunol. 56 330-336.
132. A.P. Weetman, S.B. Cohen, D.A. Oleesky and B.P. Morgan (1989) Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease. Clin. Exper. Immunol. 77 25-30.
133. A.P. Weetman, M.E. Yateman, P.A. Ealey, C.M. Black, C.B. Reimer, R.C. Williams, B. Shine and N.J. Marshall (1990) Thyroidstimulating antibody activity between different immunoglobulin G subclasses. J. Clin. Invest. 86 723-727.
134. A.P. Weetman, N. Tandon and B.P. Morgan (1992) Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet 340 633-636.
135. G. Wick, H.P. Brezinschek, K. Hala, H. Dietrich, H. Wolf and G. Kroemer (1989) The obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis. Adv. Immunol. 47 433-500.
136. R.C. Williams, N.J. Marshall, K. Kilpatrick, J. Montano, P.M. Brickell, M. Goodall, P.A. Ealey, B. Shine, A.P. Weetman and R.K. Craig (1988) Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms. J. Clin. Invest. 82 1306-1312.
137. B. Winsa, H.O. Adami, R. Bergstrom, A. Gamstedt, P.A. Dahlberg, U. Adamson, R. Jansson and A. Karlsson (1991) Stressful life events and Graves' disease. Lancet 338 1475-1479.
138. Z. Wu, E.R. Podack, J.M. McKenzie, K.J. Olsen and M. Zakarija (1994) Perforin expression by thyroid-infiltrating T-cells in autoimmune thyroid disease. Clin. Exper. Immunol. 98 470-477.
139. K. Yamaguchi, N. Shimojo, S. Kikuoka, A. Hoshioka, A. Hirai, K. Tahara, L.D. Kohn, Y. Kohno and H. Niimi (1997) Genetic control of anti-thyrotropin receptor antibody generation in H-2K mice immunized with thyrotropin receptor-transfected fibroblasts. J. Clin. Endocrinol. Metab. 82 4266-4269.
140. T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman and L.J. DeGroot (1995) CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J. Clin. Endocrinol. Metab. 80 41-45.
141. M. Zakarija (1983) Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. J. Clin. Lab. Immunol. 10 77-85.